13 Best Stocks To Buy Before Recessions

Published on February 21, 2024 at 9:12 am by Fahad Saleem in Hedge Funds, News

In this article, we will take a detailed look at the 13 Best Stocks To Buy Before Recessions. For a quick overview of such stocks, read our article 5 Best Stocks To Buy Before Recessions.

The hard landing versus soft landing debate is back in the limelight amid latest data points showing the stubbornness of inflation and warnings from some analysts that amid the fast depleting household savings in the US, the economy might not be able to endure the pressures like it did last year.

Hard Landing Probability is Rising

A Reuters report recently said that in the options market bets are rising for a hard landing scenario. The report said in the options market there has been a rise in demand for so-called “receiver swaptions,” a type of trade that pays off when interest rates fall. The Reuters report also quoted Bruno Braizinha, interest rates strategist at BoFA Securities in New York, who said that risks are “roughly balanced between a hard landing and no landing” from a macroeconomic perspective. However, the analyst reportedly said the options market bets are now tilting towards a hard landing scenario.

“But the options market is pricing those probabilities more skewed towards a hard landing,” Braizinha said.

Andrew Hollenhorst, Citi chief U.S. economist, recently said while talking to CNBC that he does not see a soft landing scenario in the data. The analyst pointed to a decline in retail sales in the US and high inflation numbers for this thesis. Hollenhorst said while the US economy was in a strong position near the end of 2023, latest data is showing signs of troubles to come. He said the latest jobs report shows a decline in the number of hours people are working and a dip in full-time jobs. He also sees a decline in labor market jobs like restaurants, which he believes is an important indicator for the economy.

Methodology

In this context, it might be the right time to see which recession-proof stocks smart money investors are piling into to weather the coming storm. Stocks from sectors like healthcare, consumer defensive and utilities perform well during recessions. For this article we first listed down holdings of key ETFs that constitute recession-proof portfolios like Goldman Sachs’ Defensive Equity ETF, Invesco Defensive Equity ETF, The Health Care Select Sector SPDR Fund (XLV), The Utilities Select Sector SPDR Fund (XLU), etc. and gauged hedge fund sentiment for these holdings. From these stocks we picked 13 stocks with the highest number of hedge fund investors. We tried to pick best stocks to buy before recessions from different sectors and industries to make our list more diversified.

Hedge funds’ top 10 consensus stock picks outperformed the S&P 500 Index by more than 140 percentage points over the last 10 years (see the details here).

13. AbbVie Inc (NYSE:ABBV)

Number of Hedge Fund Investors: 73

AbbVie Inc (NYSE:ABBV) is a text-book name to buy for recessions and troubled economic times. The stock has a dividend yield of about 3.5% as of February 8. The pharmaceutical company AbbVie Inc’s (NYSE:ABBV) shares have gained about 21% over the past one year. AbbVie Inc (NYSE:ABBV) has decades of consistent dividend increases under its belt.

As of the end of the third quarter of 2023, 73 hedge funds out of the 910 funds tracked by Insider Monkey had stakes in AbbVie Inc (NYSE:ABBV) . The most notable stakeholder of AbbVie Inc (NYSE:ABBV) was Paul Marshall and Ian Wace’s Marshall Wace LLP which owns a $582 million stake in AbbVie Inc (NYSE:ABBV).

Carillon Eagle Mid Cap Growth Fund made the following comment about AbbVie Inc. (NYSE:ABBV) in its Q3 2023 investor letter:

“AbbVie Inc. (NYSE:ABBV) reported strong, broad-based second-quarter performance that exceeded analysts’ expectations. The company’s raised guidance was a nice recovery after its mildly disappointing first-quarter report.”

12. Cigna Group (NYSE:CI)

Number of Hedge Fund Investors: 74

Cigna Group (NYSE:CI) is another name in the healthcare industry that is among the favorites of smart money managers when economic downturns begin. BofA recently said in its report that it believes market “narrowness” will shift and returns will spread to other companies as well. It is bullish on several companies, including Cigna Group (NYSE:CI), for which it has a $370 price target. This price target shows a strong upside potential to the stock’s current price of $341.

A total of 74 hedge funds out of the 910 funds tracked by Insider Monkey had stakes in Cigna Group (NYSE:CI).

Here is what Davis New York Venture Fund has to say about The Cigna Group (NYSE:CI) in its Q3 2023 investor letter:

“In the attractive healthcare sector, we look beyond the obvious to identify businesses that simultaneously have exposure to this growth industry and also trade at low prices. We’re especially drawn to companies like Cigna Group, whose products or services play a part in helping to mitigate healthcare’s constantly rising costs. The healthcare industry has been a growing part of the U.S. economy for decades. As a result, many companies in this sector trade at high valuations reflecting their robust but well-known reputation for growth. For value-conscious investors like us, investing in healthcare requires looking beyond the obvious to identify businesses that have exposure to this growth industry but which trade at low prices. Furthermore, recognizing that the constantly rising cost of healthcare cannot go on forever, we have been particularly drawn to companies whose products or services play some role in managing or reducing the cost of care. As a result, we have positions in Cigna Group, a well-regarded provider of managed care.

11. Procter & Gamble Co (NYSE:PG)

Number of Hedge Fund Investors: 75

Procter & Gamble Co (NYSE:PG) is one of the most popular defensive stocks both retail and institutional investors like. Procter & Gamble Co’s (NYSE:PG) consistent dividend increases for over six decades and its diversified business model make it an ideal stock to own before or during recessions.

A total of 75 hedge funds in Insider Monkey’s database of 910 hedge funds had stakes in Procter & Gamble Co (NYSE:PG). The most significant stake in Procter & Gamble Co (NYSE:PG) is owned by Ken Fisher’s Fisher Asset Management which owns a $1.5 billion stake in Procter & Gamble Co (NYSE:PG).

Madison Sustainable Equity Fund stated the following regarding The Procter & Gamble Company (NYSE:PG) in its fourth quarter 2023 investor letter:

“We sold The Procter & Gamble Company (NYSE:PG). After two years of strong pricing growth, the company is facing slower market growth in both the US and Europe. China, the company’s second largest individual market, is facing a protracted downturn with poor visibility on when fundamentals will improve.”

10. DexCom Inc (NASDAQ:DXCM)

Number of Hedge Fund Investors: 78

Glucose monitoring systems company DexCom Inc (NASDAQ:DXCM) is a notable stock to buy before recessions because the demand of DexCom Inc’s (NASDAQ:DXCM) products is relatively safe from the effects of economic downturns.

In December, UBS published its list of top global stocks. DexCom Inc (NASDAQ:DXCM) was part of the list.

A total of 78 hedge funds tracked by Insider Monkey had stakes in DexCom Inc (NASDAQ:DXCM). The biggest stake in DexCom Inc (NASDAQ:DXCM) is owned by Israel Englander’s Millennium Management which owns a $259 million stake in DexCom Inc (NASDAQ:DXCM).

Carillon Eagle Mid Cap Growth Fund stated the following regarding DexCom, Inc. (NASDAQ:DXCM) in its fourth quarter 2023 investor letter:

“DexCom, Inc. (NASDAQ:DXCM) is a developer and manufacturer of continuous glucose monitors (CGMs). CGMs are currently used by Type 1 and insulin-intensive Type 2 diabetics to control blood glucose levels more effectively than intermittent fi nger sticks. The company’s stock declined in 2023 due to investor concerns surrounding the potential impact that glucagon-like peptide 1 (GLP-1) medications could have on demand for their products. Contrary to initial belief, internal analysis uncovered that patients taking GLP-1s used CGMs at twice the rate of patients not on GLP-1s. This, and the company’s excellent results for the third quarter, caused the stock price to rebound significantly.”

9. Intuitive Surgical, Inc. (NASDAQ:ISRG)

Number of Hedge Fund Investors: 78

Intuitive Surgical, Inc. (NASDAQ:ISRG) has already defied all fears and downturns over the past few months as the stock is up about 57% over the past one year.

Intuitive Surgical, Inc. (NASDAQ:ISRG) is working on robotic products that are used in surgeries.

Insider Monkey’s database shows that 78 hedge funds tracked by Insider Monkey were long Intuitive Surgical, Inc. (NASDAQ:ISRG) as of the end of the third quarter.

Baron Health Care Fund stated the following regarding Intuitive Surgical, Inc. (NASDAQ:ISRG) in its fourth quarter 2023 investor letter:

“Additional tailwinds to performance came from robotic surgical system pioneer Intuitive Surgical, Inc. (NASDAQ:ISRG). We believe Intuitive Surgical will continue to innovate and launch new products that enhance surgical outcomes, and we think the company has a long runway for growth.

Intuitive Surgical, Inc. sells the da Vinci surgical robotic system for minimally invasive surgical procedures. The stock rose on investor speculation that the company could launch a new robotic system in 2024. We believe Intuitive Surgical will continue to innovate and launch new products that enhance surgical outcomes, and we think the company has a long runway for growth.”

8. Walmart Inc (NYSE:WMT)

Number of Hedge Fund Investors: 80

Walmart Inc (NYSE:WMT) is a classic name to own before or during recessions. Everyone needs to buy groceries and essentials and Walmart Inc (NYSE:WMT) is a name that comes to mind when you think of buying groceries. As of February 2023 Walmart Inc (NYSE:WMT) is a dividend kind, having raised its payouts consistently for the past 50 years .

Earlier this month, CFRA published its list of 5-star rated dividend aristocrat stocks. Walmart Inc (NYSE:WMT) made it to the list.

A total of 80 hedge funds tracked by Insider Monkey had stakes in Walmart Inc (NYSE:WMT).

7. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Investors: 84

With decades of dividend increases and a strong and diversified business model, Johnson & Johnson (NYSE:JNJ) ranks seventh in our list of the best stocks to buy before recessions. BofA Securities recently published a list of least-shorted stocks. Johnson & Johnson (NYSE:JNJ) made it to the list.

A total of 84 hedge funds in Insider Monkey’s database of 910 hedge funds had stakes in Johnson & Johnson (NYSE:JNJ).

ClearBridge Large Cap Value Strategy made the following comment about Johnson & Johnson (NYSE:JNJ) in its Q3 2023 investor letter:

“The health care space provided some opportunities in the quarter, as we increased our exposure to medical device company Becton, Dickinson as well as large cap pharmaceutical company Johnson & Johnson (NYSE:JNJ). Johnson & Johnson recently spun out its consumer health care business, becoming a more focused yet broadly diversified pharmaceutical and medtech company.”

6. UnitedHealth Group Inc (NYSE:UNH)

Number of Hedge Fund Investors: 104

UnitedHealth Group Inc (NYSE:UNH) is one of the top healthcare stocks to buy and hold for recessions. Recently, BofA set a price target of $675 for UnitedHealth Group Inc (NYSE:UNH) stock. This price target shows a huge upside potential compared to the current stock price of $519.

As of the end of the third quarter of 2023, 104 hedge funds tracked by Insider Monkey had stakes in UnitedHealth Group Inc (NYSE:UNH).

Wedgewood Partners stated the following regarding UnitedHealth Group Incorporated (NYSE:UNH) in its fourth quarter 2023 investor letter:

“UnitedHealth Group Incorporated (NYSE:UNH) contributed less to portfolio performance than the majority of our holdings during the quarter. The Company reported double-digit revenue, operating earnings and earnings per share growth during their third quarter. The Company has been able to adjust pricing in its health care segment to keep up with medical cost inflation while working with its Optum units to deliver more value-based care that replaces the traditional fee for service health care model. Value-based care is a sensible, long-term growth opportunity for the Company to pursue and also differentiates it from the vast majority of healthcare providers, particularly as it relates to Medicare patients. For example, the Company’s value-based care programs provide more preventative care opportunities and home-based care visits for patients which helps save the U.S. healthcare system billions in unnecessary spending while also providing patients with better outcomes, as diseases and behaviors are caught or corrected at earlier stages. The Company has invested in several core assets over many years to execute this value-based strategy and it will become the standard of care as the proportion of people in the U.S. with healthcare insurance coverage continues to reach new highs.”

Click to continue reading and see 5 Best Stocks To Buy Before Recessions.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on May 1, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

Published on May 2, 2024 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up